R
Robert M. Chanock
Researcher at National Institutes of Health
Publications - 344
Citations - 25937
Robert M. Chanock is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Virus & Influenza A virus. The author has an hindex of 90, co-authored 344 publications receiving 25490 citations. Previous affiliations of Robert M. Chanock include RMIT University & University of Maryland, Baltimore.
Papers
More filters
Journal ArticleDOI
A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals.
Dennis R. Burton,Carlos F. Barbas,Mats A. A. Persson,Scott Koenig,Robert M. Chanock,Richard A. Lerner +5 more
TL;DR: A panel of human monoclonal antibody Fab fragments has been generated against the surface glycoprotein gp120 of type 1 human immunodeficiency virus (HIV) by antigen selection from a random combinatorial library expressed on the surface of filamentous phage.
Journal ArticleDOI
Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a pplo
TL;DR: Evidence is provided which firmly associates the agent first recovered by Eaton with lower respiratory tract illness of man and the demonstration that naturally acquired antibody offered protection against such illness supports the contention that the agent is a respiratory tract pathogen.
Journal ArticleDOI
Epidemiology of respiratory syncytial virus infection in washington, d.c.i. importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection
Hyun Wha Kim,Julita O. Arrobio,Carl D. Brandt,Barbara C. Jeffries,Gloria Pyles,Jannie L. Reid,Robert M. Chanock,Robert H. Parrott +7 more
Journal ArticleDOI
Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development
TL;DR: It should be possible to introduce defined changes into infectious RSV using the M2(ORF1) protein, consistent with its recent identification as a transcription elongation factor and confirms its importance for RSV gene expression.
Journal ArticleDOI
Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease.
TL;DR: A sharp decrease in the rate of virus isolation during the winter of 1965-66 was noted, similar to that reported by others, and the recovery and properties of these 6 viruses form the basis of this report.